Reuters logo
BRIEF-Cidara Therapeutics says data from clinical studies support antifungal CD101
December 14, 2016 / 1:57 PM / a year ago

BRIEF-Cidara Therapeutics says data from clinical studies support antifungal CD101

Dec 14 (Reuters) - Cidara Therapeutics Inc

* Cidara Therapeutics Inc says data from preclinical and clinical studies evaluating company’s novel echinocandin antifungal cd101

* Cidara Therapeutics -data showcase compound’s discovery through development, potential to expand echinocandin utility across multiple infectious-disease indications Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below